Bio-Rad Laboratories, Inc. Stock
Equities
BIO
US0905722072
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
286.1 USD | -0.39% | -1.16% | -11.40% |
Financials (USD)
Sales 2024 * | 2.66B | Sales 2025 * | 2.79B | Capitalization | 8.16B |
---|---|---|---|---|---|
Net income 2024 * | 294M | Net income 2025 * | 285M | EV / Sales 2024 * | 2.81 x |
Net cash position 2024 * | 674M | Net cash position 2025 * | 828M | EV / Sales 2025 * | 2.62 x |
P/E ratio 2024 * |
27.8
x | P/E ratio 2025 * |
28.6
x | Employees | 8,030 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.02% |
Latest transcript on Bio-Rad Laboratories, Inc.
1 day | -0.39% | ||
1 week | -1.16% | ||
Current month | +6.06% | ||
1 month | +3.68% | ||
3 months | -13.40% | ||
6 months | -6.02% | ||
Current year | -11.40% |
Managers | Title | Age | Since |
---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 74 | 88-12-31 |
Gregory Hinckley
DFI | Director of Finance/CFO | 77 | 83-01-31 |
Andrew Last
COO | Chief Operating Officer | 64 | 19-04-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Edwards
BRD | Director/Board Member | 63 | 17-04-24 |
Alice Schwartz
FOU | Founder | 97 | 51-12-31 |
Gregory Hinckley
BRD | Director/Board Member | 77 | 17-04-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.90% | 2 M€ | 0.00% | ||
1.01% | 14 M€ | -4.84% | ||
0.76% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 286.1 | -0.39% | 283,707 |
24-05-24 | 287.2 | -1.05% | 141,582 |
24-05-23 | 290.2 | -0.54% | 241,991 |
24-05-22 | 291.8 | +0.83% | 166,240 |
24-05-21 | 289.4 | -0.83% | 175,907 |
Delayed Quote Nyse, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.40% | 8.16B | |
-7.38% | 181B | |
-0.46% | 108B | |
-6.98% | 66.12B | |
+2.65% | 50.65B | |
+5.27% | 43.11B | |
+6.47% | 40.74B | |
+19.92% | 31.6B | |
+16.18% | 25.56B | |
-7.00% | 24.16B |
- Stock Market
- Equities
- BIO Stock